$ABP - The Hidden GEM Nobody’s Watching 💎
This tiny biotech dropped from $10 to just $0.15 after IPO — no reverse split, no dilution history — and yet the market is asleep.
Here’s the kicker:
🔥 Both lead programs are FULLY FUNDED 🔥
🔹 ABP‑102: $1.75B funding from Celltrion
🔹 ABP‑201: $30M equity + $540M milestone deal from Abpro Bio
This company has zero debt, a clean cap table, and insiders just loaded up at market.
They hold global rights for major cancer and eye disease therapies, with multi-billion-dollar upside and milestone triggers ahead. And right now — it’s trading at pennies.
This is not just undervalued. It’s a once-in-a-lifetime biotech setup.
🚀 10x? Maybe.
💎 One of the biggest sleepers you’ll ever find.
📉 From $10 to $0.15
📈 Next stop? Don’t say I didn’t tell you.
GLTA and of course NFA 🤝🏼
$ABP
“$17.00 to $36.00 coming let me explain
What OCGN did in 2021 if anyone remember!! From 0.2$ to 10$ !! The company is a cancer treatment developer who got listed recently at 10$ a share and dropped all the way to 0.15 cents, now what makes it a one time life opportunity is that it’s trading around 10 million market cap while it’s fully funded by the Celltrion company which has a market cap of 28 billion usd!! No risk of diluting!! Owners been buying recently!! Has an access to a billion in funding while setting at a 10 m market cap!!”.
$PINO cannot be stopped. This is only the beginning. We will catch up to $Ponke $Brett $Pepe $Andy $Doge $Shib $Wif $Hodl
Next stop 250m market cap!! 🚂💨
@pinothedino
Such a beautiful chart. I just keep loading more while it’s cheap. Big green candles incoming for $PINO and penny land is right around the corner. @pinothedino
Reminds me of $ponke $wif $brett in the early days 💥🥊